Order Article Reprints

Jimenez C, Subbiah V, Stephen B, Ma J, Milton D, Xu M, Zarifa A, Akhmedzhanov FO, Tsimberidou A, Habra MA, et al. Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas. Cancers. 2020; 12(8):2307. https://doi.org/10.3390/cancers12082307

Jimenez, Camilo, Vivek Subbiah, Bettzy Stephen, Junsheng Ma, Denai Milton, Mingxuan Xu, Abdualrazzak Zarifa, Fechukwu Omolara Akhmedzhanov, Apostolia Tsimberidou, Mouhammed Amir Habra, and et al. 2020. "Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas" Cancers 12, no. 8: 2307. https://doi.org/10.3390/cancers12082307

Jimenez, C., Subbiah, V., Stephen, B., Ma, J., Milton, D., Xu, M., Zarifa, A., Akhmedzhanov, F. O., Tsimberidou, A., Habra, M. A., Rodon Anhert, J., Fu, S., & Naing, A. (2020). Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas. Cancers, 12(8), 2307. https://doi.org/10.3390/cancers12082307